4Bodey GP, Pan T. Mezlocillin: in vitro studies of a new broad-spectrum penicillin[J]. Antimicrob Agents Che mother,1977,11(1) :74-79.
5Campoli-Richarcls DM, Brogden RN. Sulbactam/ampicillin. A review of its antibacterial activity, pharmacokinetic properties,and therapeutic use[J]. Drugs, 1987,33 (6) : 577-609.
6Bush K,Jacoby GA, Medeiros AA. A functional classifi cation scheme for beta lactamases and its correlation with molecular structure[J]. Antimicrob Agents Chemother, 1995,39(6) :1211-1233.
7Manncke K, Springsklee M, Heizmann WR, et al. Sulbactam in combination with mezlocillin, piperacillin or cefotaxime. Clinical and bacteriological results in the treatment of severe bacterial infections[J]. Med Klin, 1991,86 (9):454-460.
8Piddock LJ,Jin YF, Turner HI.. Activity of 13 β-lactam agents combined with BRL 42715 against β-lactamase producing gram-negative bacteria compared to combina tions with clavulanic acid, tazobactam and sulbactam[J]. J Antimicrob Chemother,1993,31(1) :89-103.
9Mohanty S, Singhal R, Sood S, et al. Comparative in vitro activity of beta lactam/beta-lactamase inhibitor combina- tions against gram negative bacteria [J]. Indian J Med Res, 2005,122 (5) : 425-428.
